NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hyundai Pharm (KO: 004310)

 
004310 Technical Analysis
1.5
As on 31st Oct 2025 004310 STOCK Price closed @ 3695.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 3852.77 & Buy for SHORT-TERM with Stoploss of 3663.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

004310STOCK Price

Open 3695.00 Change Price %
High 3725.00 1 Day -30.00 -0.81
Low 3685.00 1 Week -120.00 -3.15
Close 3695.00 1 Month -195.00 -5.01
Volume 55516 1 Year -155.00 -4.03
52 Week High 5820.00 | 52 Week Low 3000.00
 
KO Korea Most Active Stocks
093230 33.00 -49.23%
093230 33.00 -49.23%
152550 383.00 19.69%
152550 383.00 19.69%
005930 107500.00 3.27%
096300 156.00 -6.02%
096300 156.00 -6.02%
168490 159.00 29.27%
168490 159.00 29.27%
006340 3650.00 0.27%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
168490 159.00 29.27%
168490 159.00 29.27%
307950 203500.00 26.08%
009420 41400.00 22.49%
009420 41400.00 22.49%
071950 4040.00 20.24%
071950 4040.00 20.24%
152550 383.00 19.69%
 
KO Korea Top Losers Stocks
002210 973.00 -65.00%
002210 973.00 -65.00%
002210 973.00 -65.00%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
093230 33.00 -49.23%
093230 33.00 -49.23%
001745 3600.00 -46.27%
 
 
004310
Daily Charts
004310
Intraday Charts
Whats New @
Bazaartrend
004310
Free Analysis
 
004310 Important Levels Intraday
RESISTANCE3772.08
RESISTANCE3747.36
RESISTANCE3732.08
RESISTANCE3716.80
SUPPORT3673.20
SUPPORT3657.92
SUPPORT3642.64
SUPPORT3617.92
 
004310 Forecast November 2025
4th UP Forecast4157.48
3rd UP Forecast4009.16
2nd UP Forecast3917.48
1st UP Forecast3825.8
1st DOWN Forecast3564.2
2nd DOWN Forecast3472.52
3rd DOWN Forecast3380.84
4th DOWN Forecast3232.52
 
004310 Weekly Forecast
4th UP Forecast3878.07
3rd UP Forecast3819.36
2nd UP Forecast3783.07
1st UP Forecast3746.78
1st DOWN Forecast3643.23
2nd DOWN Forecast3606.94
3rd DOWN Forecast3570.65
4th DOWN Forecast3511.94
 
004310 Forecast2025
4th UP Forecast10680.4
3rd UP Forecast8440.13
2nd UP Forecast7055.38
1st UP Forecast5670.63
1st DOWN Forecast1719.38
2nd DOWN Forecast334.63
3rd DOWN Forecast-1050.13
4th DOWN Forecast-3290.38
 
 
004310 Other Details
Segment EQ
Market Capital 167270400000.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
004310 Address
004310
 
004310 Latest News
 
Your Comments and Response on Hyundai Pharm
 
004310 Business Profile
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antiviral, cardiovascular, central nervous system, contraceptive, depilatory, dermatological, diagnostic, digestive system, endocrine system, ENT, hemostatic, hormone therapy, musculo-skeletal system, ophthalmic, oral disease, respiratory, urogenital system, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial, arthritis, constipation, disinfectant, lip care, nutrition, and wound healing. It also develops products for the treatment of type 2 diabetes, bronchitis, senile disease, and osteoporosis. The company was founded in 1965 and is headquartered in Seoul, South Korea. Address: Hyundai Pharm Building, Seoul, South Korea, 06121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service